Arthur J. Higgins, Director, President and CEO at Assertio Therapeutics, Inc (ASRT), bought 10,000 shares at $4.17 ($42K) on 2019-03-14, disclosed to the SEC on 2019-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ECL | SELL | 2024-05-08 | $1.0M | — | Filing → |
| ZBH | BUY | 2023-08-25 | $116K | — | Filing → |
| ECL | SELL | 2023-06-15 | $870K | — | Filing → |